will be ready to dish out an Omicron-specific booster vaccine this fall, its chief medical officer has said — as U.S. Covid cases surge 51 percent over the past two weeks.The leading vaccine manufacturer's Dr Paul Burton revealed it was now testing a shot against likely to be 'even more superior' than its current jab — with 'large amounts' set to be available as soon as this September.All Covid vaccines are currently based on the original Wuhan virus, amid hesitancy among manufacturers to spend months making a new jab in case another variant emerges. If approved, Moderna's shot would be the first to target the Omicron variant.
Load More
Load More